References
Bethea CL, Lu NZ, Gundlah C, Streicher JM (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23(1):41–100
Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157(6):924–930
Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, Cohen LS (2007) Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 68(6):943–950
Kugaya A, Epperson CN, Zoghbi S et al (2003) Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160(8):1522–1524
Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M (2004) Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55(4):406–412
Payne JL, Klein SR, Zamoiski RB, Zandi PP, Bienvenu OJ, Mackinnon DF, Mondimore FM, Schweizer B, Swartz KL, Crowe RP, Scheftner WA, Weissman MM, Levinson DF, DePaulo JR Jr, Potash JB, NIMH Genetics Initiative Bipolar Disorder Consortium (2009) Premenstrual mood symptoms: study of familiality and personality correlates in mood disorder pedigrees. Arch Womens Ment Health 12(1):27–34
Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44(9):839–850
Schmidt PJ, Nieman L, Danaceau MA et al (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183(2):414–420
Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58(6):529–534
Soares CN, Poitras JR, Prouty J (2003) Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 20(2):85–100
Stahl S (2001) Effects of estrogen on the central nervous system. JClin Psychiatry 62(5):317–318
Stahl M (2009) Vasomotor symptoms and depression in women, Part 1. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive disorder. J Clin Psychiatry 70(1):11–12
Conflict of interest
The author declares that he has no conflict of interest related to this article. Over the past 2 years, Dr. Soares has received research grants from NARSAD Foundation, Hamilton Community Foundation, Allergen NCE, Canadian Institute of Health research (CIHR), Eli Lilly, AstraZeneca, and Wyeth Pharmaceuticals. He has worked as a consultant and /or speakers' bureau member for Eli Lilly, AstraZeneca, Wyeth Pharmaceuticals, Lundbeck and Bayer Pharmaceuticals.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Soares, C.N. DSM-V and reproductive-related psychiatric disorders: a closer look at windows of vulnerability. Arch Womens Ment Health 13, 15–16 (2010). https://doi.org/10.1007/s00737-009-0116-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-009-0116-z